問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
陳天華
下載
2020-12-14 - 2024-03-31
Condition/Disease
Test Drug
Participate Sites8Sites
Recruiting8Sites
2022-07-01 - 2028-12-31
Participate Sites5Sites
Recruiting5Sites
2023-12-15 - 2030-12-31
Not yet recruiting5Sites
Recruiting3Sites
2025-10-01 - 2030-12-31
Participate Sites2Sites
Recruiting2Sites
2020-08-31 - 2027-12-31
Esophageal Squamous Cell Carcinoma(ESCC)
Durvalumab
Participate Sites11Sites
Recruiting11Sites
2023-09-15 - 2025-02-28
Not yet recruiting4Sites
Recruiting1Sites
2025-01-01 - 2026-12-31
2021-10-01 - 2025-12-31
Participate Sites3Sites
2024-12-01 - 2031-05-31
Participate Sites6Sites
Recruiting6Sites
2025-01-01 - 2029-12-12
Participate Sites12Sites
Recruiting12Sites
全部
